Previous studies have shown expression of STAT3 and activated STAT3 (pSTAT3) within tumour cells to be associated with outcome in colorectal, pancreatic and prostate cancers; however, there is limited evidence in the literature exploring STAT3 expression within the stroma.5, 6, 15. This evidence concerns the gene STAT3 and prostate carcinoma.